Canopy Growth (CGC) Payables (2017 - 2026)
Canopy Growth (CGC) posted Payables of $45.5 million for Q1 2026, up 217.55% sequentially from $14.3 million in Q4 2025, and up 87.73% YoY from $24.2 million in Q1 2025.
Canopy Growth (CGC) Payables (2017 - 2026) Analysis & Trends
Canopy Growth has reported Payables for 10 years, with the latest figure at $45.5 million in Q1 2026.
- Quarterly Payables rose 87.73% year-over-year to $45.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.5 million (up 87.73% YoY) and the FY2026 annual result came in at $45.5 million, up 87.73% from the prior year.
- Payables climbed to $45.5 million in Q1 2026 per CGC's latest filing, from $14.3 million in the prior quarter.
- Over five years, Payables peaked at $95.4 million in Q1 2024 and troughed at $13.2 million in Q3 2025.
- A 5-year average of $33.3 million and a median of $23.5 million in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables jumped 305.32% in 2024, then sank 74.63% in 2025.
- Over 5 years, Payables stood at $46.5 million in 2022, then sank by 59.2% to $19.0 million in 2023, then advanced by 9.08% to $20.7 million in 2024, then plunged by 30.85% to $14.3 million in 2025, then jumped by 217.55% to $45.5 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $45.5 million, $14.3 million, and $13.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 986.00 Mn |
| 10 | Canopy Growth | 441.18 Mn | 194.17 Mn | 16.08 Mn | 40.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.10 Mn |
| Mar 31, 2026 | 45.46 Mn |
| Dec 31, 2025 | 14.32 Mn |
| Sep 30, 2025 | 13.18 Mn |
| Jun 30, 2025 | 17.38 Mn |
| Mar 31, 2025 | 24.22 Mn |
| Dec 31, 2024 | 20.70 Mn |
| Sep 30, 2024 | 13.46 Mn |
| Jun 30, 2024 | 18.64 Mn |
| Mar 31, 2024 | 95.45 Mn |
| Dec 31, 2023 | 18.98 Mn |
| Sep 30, 2023 | 16.95 Mn |
| Jun 30, 2023 | 42.85 Mn |
| Mar 31, 2023 | 23.55 Mn |
| Dec 31, 2022 | 46.51 Mn |
| Sep 30, 2022 | 52.29 Mn |
| Jun 30, 2022 | 50.71 Mn |
| Mar 31, 2022 | 50.74 Mn |
| Dec 31, 2021 | 53.82 Mn |
| Sep 30, 2021 | 74.97 Mn |